ﬁle:///The Cas e Agains t Nuclear PowerTHE CASE AGAINST NUCLEAR POWERGORDON TAYLOR2011-06-06The critical issue for nuclear power is the consequences of a major radioactive release. These were predicted in theSandia CRAC-2 study as 42,000 to 100,000 early deaths. They were confirmed empirically by Chernobyl, whichcontaminated huge areas of the Ukraine, Belarus and Russia as well as 40% of Europ
Conversely, injection forms, though being painful and needing help of medical personnel for application, help to quickly achieve necessary concentration of preparation in blood buy antibiotics online Antibiotic is usually chosen in an empiric way (at random). But when choosing one is obligatory guided by definite rules.
Ek 2010 all surface cleaner msdsCRETE COLORS INTERNATIONAL, LLC
MATERIAL SAFETY DATA SHEET
FOR CHEMICAL EMERGENCY
Spill, Leak, Fire Exposure or Accident
CALL INFOTRAC – Day or Night:
Outside the United States Call Collect:
PRODUCT TRADE NAME:
III TYPICAL PHYSICAL DATA
(Butyl Acetate = 1)
IV FIRE AND EXPLOSION HAZARD DATA
C2 Maintenance™ is a clear blue liquid. Concentrate contact with eyes may cause moderate irritation. Skin contact may result in irritation. Always wear appropriate personal protective equipment when using this product. FLASH POINT (METHOD): >212F (ASTM D 3278)
FLAMMABLE LIMITS: Not applicable.
EXTINGUISHING MEDIA: Use water fog, foam, dry chemical, or CO2
SPECIAL FIRE FIGHTING PROCEDURES: Fire fighters should be equipped with self-contained breathing apparatus and turn-out
UNUSUAL FIRE AND EXPLOSION HAZARDS: There are no known unusual fire or explosion hazards.
HEALTH HAZARD DATA
PRIMARY ROUTES OF EXPOSURE: Eye and skin contact.
CARCINOGEN INFORMATION: Contains no listed carcinogens.
MEDICAL CONDITIONS AGGRAVATED BY OVEREXPOSURE: Pre-existing skin and eye disorders may be aggravated by
EFFECTS OF OVEREXPOSURE: Acute: Concentrate eye contact may cause moderate eye irritation. Ready-to-use solution
contact with eyes and skin may result in irritation. Ingestion may result in gastric disturbances. Chronic: None
EYE CONTACT: Concentrate contact may cause moderate eye irritation. Ready-to-use dilution contact may irritate eyes,
producing redness and swelling of the conjunctiva. SKIN CONTACT: This product may cause skin irritation and drying of skin with prolonged contact.
INHALATION: Mists or vapors may be irritating to upper respiratory tract, although this is not expected to be a relevant route of
INGESTION: May cause nausea and vomiting, as well as other gastric disturbances. Not expected to be a relevant route of
EMERGENCY AND FIRST AID PROCEDURES:
EYE CONTACT: Immediately flush exposed area with clean water for at least 15 minutes. Seek medical attention.
SKIN CONTACT: Immediately flush exposed area with clean water to remove all residues. If irritation persists, get medical
attention. Remove contaminated clothing. Launder contaminated clothing before reuse. INHALATION: Remove to fresh air. If breathing is difficult, give oxygen. Get medical attention.
INGESTION: Do not give liquids if victim is unconscious or very drowsy. Otherwise, give no more than 2 glasses of water and
induce vomiting by giving 30 cc (2 Tablespoons) syrup of Ipecac.* If Ipecac is unavailable, give two glasses of water and induce vomiting by touching finger to the back of the victim’s throat. Keep victim’s head below hips while vomiting. Get medical attention. * If victim is a child, give no more than one glass of water and 15 cc (1 Tablespoon) syrup of Ipecac. If symptoms such as
loss of gag reflex, convulsions or unconsciousness occur before emesis, gastric lavage should be considered following
intubation with a cuffed endotracheal tube.
VI REACTIVITY DATA
CONDITIONS TO AVOID: Extreme heat.
INCOMPATIBILITY (MATERIALS TO AVOID): Strong acids and strong oxidizing agents.
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS: Carbon monoxide and other unidentified organic compounds
VII SPILL OR LEAK PROCEDURES
SPILL, LEAK, WASTE DISPOSAL PROCEDURES: CAUTION: Wear appropriate protective safety equipment to prevent skin and
eye contact. Dike area to contain spilled material and use inert absorbent or a wet-vac to pick up material for disposal. WASTE DISPOSAL METHODS: This product is readily biodegradable in sewage treatment processes. Based on Federal EPA
solid waste definitions and waste water pretreatment guidelines, rinse water generated during the use of this material can be disposed of to sanitary sewer. The product as supplied is not classified as a hazardous waste under federal regulations. Consult appropriate federal, state, and local regulatory agencies to ascertain proper disposal procedures. VIII SPECIAL PROTECTION INFORMATION
RESPIRATORY PROTECTION: None necessary using common application methods.
VENTILATION: No special ventilation required.
PROTECTIVE CLOTHING: Wear protective clothing as necessary to minimize contact.
PROTECTIVE GLOVES: Wear impermeable gloves when handling concentrate and as needed to avoid prolonged contact to ready-to-
EYE PROTECTION: Wear eye protection appropriate to eliminate splash hazards to eyes and suitable for jobsite dilution and
OTHER PROTECTIVE EQUIPMENT: Eyewash should be accessible from work area. Provide fresh water for body rinsing.
IX SPECIAL PRECAUTIONS
WORK PRACTICES: Proper work practices and planning should be utilized to avoid contact with workers, passersby, and non-target
surfaces. Do not atomize during application. See the Product Data sheet and label for precautions to be taken during use. PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE: Wear appropriate safety equipment and clothing. Do not get in
eyes, on skin, or on clothing. Do not take internally. Store in a cool, dry, well-ventilated place. Never touch eyes or face with hands or gloves that may be contaminated with this product. Keep containers closed when not dispensing product. Use care around spilled material because it will be slippery. OTHER PRECAUTIONS: Wash thoroughly after handling. Do not eat, drink, or smoke in work areas.
SHIPPING: This product is not regulated in domestic or international shipment.
SARA 313: Contains no listed ingredients.
California Proposition 65: Contains no listed ingredients.
HMIS Ratings: Concentrate = 2,0,0,X Ready-to-use solution = 1,0,0,X
Date of Revision: April 30, 2010
For Product Manufactured After: May 1, 2010
Changes: Formulary revision review.
Item #: PLC246084
Approved By: Regulatory Department
The information contained on the Material Safety Data Sheet has been compiled from data considered accurate. This data is
believed to be reliable, but it must be pointed out that values for certain properties are known to vary from source to sourc e.
Crete Colors International, LLC expressly disclaims any warranty express or implied as well as any liability for any
injury or loss arising from the use of this information or the materials described. This data is not to be construed as
absolutely complete since additional data may be desirable when particular conditions or circumstances exist. It is the
responsibility of the user to determine the best precautions necessary for the safe handling and use of this product for his
unique application. This data relates only to the specific material designated and is not to be used in combination with any
other material. Many federal and state regulations pertain directly or indirectly to the product's end use and disposal of
containers and unused material. It is the purchaser's responsibility to familiarize himself with all applicable regulations.
DATE OF PREPARATION:
April 30, 2010
Journal of the InternationalSociety of Sports NutritionThis Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formattedPDF and full text (HTML) versions will be made available soon. The effects of peppermint on exercise performance Journal of the International Society of Sports Nutrition 2013, 10 :15 Article type Submission date Acceptance date